Beta Bionics (BBNX) Income towards Parent Company (2024 - 2026)
Beta Bionics' (BBNX) quarterly Income towards Parent Company came in at -$23.4 million in Q2 2026, down 38.74% year-over-year from -$38.2 million in Q2 2025, and down 6.88% quarter-over-quarter from -$21.9 million in Q1 2026.
Analysis
Beta Bionics (BBNX) Income towards Parent Company (2024 - 2026) Analysis & Trends
Beta Bionics has disclosed Income towards Parent Company across 3 years of filings, most recently posting -$23.4 million for Q2 2026.
- In Q2 2026, Income towards Parent Company fell 38.74% year-over-year to -$23.4 million; the TTM figure through Jun 2026 stood at -$73.0 million (down 31.93% YoY), while the FY2025 annual figure was -$60.7 million, down 46.94% from the prior year.
- Income towards Parent Company came in at -$23.4 million for Q2 2026 at Beta Bionics, down from -$21.9 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$8.3 million in Q1 2024 to a low of -$23.4 million in Q2 2026.
- Average Income towards Parent Company over 3 years is -$14.7 million, with a median of -$13.8 million recorded in 2025.
- The largest YoY upside for Income towards Parent Company was 11.42% in 2025 against a maximum downside of 94.92% in 2025.
- Over 3 years, Income towards Parent Company stood at -$12.1 million in 2024, then declined by 11.42% to -$13.5 million in 2025, then plunged by 73.78% to -$23.4 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$23.4 million in Q2 2026, -$21.9 million in Q1 2026, and -$13.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Beta Bionics | 786.45 Mn | 605.96 Mn | 18.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.40 Mn |
| Mar 31, 2026 | -21.90 Mn |
| Dec 31, 2025 | -13.47 Mn |
| Sep 30, 2025 | -14.21 Mn |
| Jun 30, 2025 | -16.87 Mn |
| Mar 31, 2025 | -16.21 Mn |
| Dec 31, 2024 | -12.09 Mn |
| Sep 30, 2024 | -10.15 Mn |
| Jun 30, 2024 | -10.79 Mn |
| Mar 31, 2024 | -8.31 Mn |